Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Eton Pharmaceuticals (ETON) Other Accumulated Expenses: 2023-2025

  • Eton Pharmaceuticals' Other Accumulated Expenses was N/A to $675,000 in Q1 2025 from the same period last year, while for Mar 2025 it was $675,000, marking a year-over-year change of. This contributed to the annual value of $5.4 million for FY2023, which is N/A change from last year.
  • As of Q1 2025, Eton Pharmaceuticals' Other Accumulated Expenses stood at $675,000, which was down 86.16% from $4.9 million recorded in Q3 2024.
  • Eton Pharmaceuticals' 5-year Other Accumulated Expenses high stood at $5.4 million for Q4 2023, and its period low was $675,000 during Q1 2025.
  • For the 3-year period, Eton Pharmaceuticals' Other Accumulated Expenses averaged around $3.6 million, with its median value being $4.9 million (2024).